Cancer Prevention News and Research

RSS

Experimental therapy eliminates pancreatic precancerous cells in mice study

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors.

12 Mar 2026

New structural insights pave way for hantavirus vaccines

Hantaviruses, transmitted from rodents to people, have a death rate approaching 40%. They're found around the world, and because there are no approved vaccines or treatments, they're among the pathogens of highest concern for future pandemics.

27 Feb 2026

Routine terminal ileum intubation and biopsy: A standard practice for colonoscopy completion

Terminal ileum intubation is considered the completion step of colonoscopy and is usually performed to assess the ileum.

27 Feb 2026

New approach to reducing radiation toxicity

Radiation therapy is highly effective at killing cancer cells, but it often harms healthy skin around the treatment area, a common side effect experienced by up to 95% of cancer patients undergoing treatment. In worst-case scenarios, it can result in delayed or halted treatment.

26 Feb 2026

Study reveals hidden internal structure within biomolecular condensates

Cells rely on biomolecular condensates to coordinate essential biological processes without surrounding membranes.

25 Feb 2026

Daily aspirin not reliable for preventing bowel cancer

Daily aspirin use does not offer a quick or reliable way to prevent bowel cancer in the general population and carries immediate risks of serious bleeding, a new Cochrane review finds.

25 Feb 2026

Colonoscopy and FIT at age 60 catch colorectal cancer earlier

The SCREESCO trial reveals that colorectal cancer screening at 60 enhances early diagnosis without affecting overall mortality or increasing long-term risks.

24 Feb 2026

New approach better predicts chemotherapy response in patients with triple-negative breast cancer

Researchers at The University of Texas MD Anderson Cancer Center have developed a new computational approach designed to better account for changes in gene expression within tumors relative to their unique microenvironments.

17 Feb 2026

Rising lung cancer in never smokers demands urgent research focus

Lung cancer patients who have never smoked make up a significant and growing share of global lung cancer cases, yet remain an understudied group, according to a new review written by UCL (University College London) researchers.

12 Feb 2026

One in five US women prefer at-home HPV screening

National data shows women who experience healthcare discrimination favor at-home HPV testing, raising questions about trust and access in screening guidelines.

11 Feb 2026

New analysis asks if alcohol guidance needs stronger trials to settle the health debate

The viewpoint reviews conflicting evidence on alcohol consumption, highlighting discrepancies between observational studies, genetic analyses, and public health guidance. It concludes that large randomized trials comparing alcohol moderation versus cessation are needed to clarify long-term health effects.

9 Feb 2026

American women show varied preferences for in-clinic versus at-home cervical cancer screening

American women now have the option of screening for cervical cancer at home, using newly approved self-collection tools.

7 Feb 2026

Triple negative breast cancer cells use new strategy to boost metastatic ability

Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize, or spread to other organs.

6 Feb 2026

World Cancer Day marks broader access to NCCN patient resources

The National Comprehensive Cancer Network (NCCN)-an alliance of leading cancer centers based in the United States-and the NCCN Foundation® is honoring World Cancer Day with an announcement about more frequent updates to its free educational resources intended to empower shared decision-making.

4 Feb 2026

Global analysis reveals up to four in ten cancer cases could be prevented

Up to four in ten cancer cases worldwide could be prevented, according to a new global analysis from the World Health Organization (WHO) and its International Agency for Research on Cancer (IARC).

4 Feb 2026

Novel RNA molecule may influence patient survival in certain blood cancers

In a recent study published in the Proceedings of the National Academy of Sciences (PNAS), researchers at the Texas A&M University Health Science Center (Texas A&M Health) identify a novel RNA molecule that plays a crucial role in preserving the integrity of a key cellular structure, nucleolus (a dense region of the cell containing a subset of crucial genetic material).

2 Feb 2026

New prevention strategy can reduce deadly ovarian cancer risk by nearly 80%

A prevention strategy developed by Canadian researchers can reduce the risk of the most common and deadly form of ovarian cancer by nearly 80 per cent, according to a new study published today in JAMA Network Open by researchers at the University of British Columbia (UBC).

2 Feb 2026

Lifetime heavy drinking sharply raises colorectal cancer risk, major US study finds

Lifetime alcohol intake, not just recent drinking, is associated with colorectal cancer risk in older adults followed in the PLCO Cancer Screening Trial. Heavy and consistent long-term drinking was linked to higher colorectal cancer risk, while alcohol cessation was associated with lower odds of early, nonadvanced adenomas.

28 Jan 2026

Study identifies a powerful strategy to overcome drug resistance in breast cancer

A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Communications, identifies a powerful strategy to overcome drug resistance in breast cancer by simultaneously targeting two key cell-cycle regulators, CDK2 and CDK4/6.

22 Jan 2026

Rice’s SynthX Center leads interdisciplinary effort to tackle rare lymphatic disorders

Rice University's SynthX Center, directed by Han Xiao, has received an up to five-year, $18 million award from the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics and pHenotyping Technologies (LIGHT) program to develop innovative solutions for lymphatic diseases.

20 Jan 2026